Fernwood Investment Management’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $5.6M | Sell |
425,424
-87,712
| -17% | -$1.16M | 1.95% | 12 |
|
|
2024
Q3 | $5.75M | Buy |
513,136
+16,850
| +3% | +$189K | 1.87% | 13 |
|
|
2024
Q2 | $5.34M | Buy |
496,286
+47,901
| +11% | +$515K | 1.65% | 14 |
|
|
2024
Q1 | $6.68M | Buy |
448,385
+25,208
| +6% | +$376K | 1.95% | 13 |
|
|
2023
Q4 | $7.66M | Buy |
423,177
+43,475
| +11% | +$787K | 2.53% | 7 |
|
|
2023
Q3 | $6.58M | Sell |
379,702
-1,025
| -0.3% | -$17.8K | 2.37% | 6 |
|
|
2023
Q2 | $6.9M | Buy |
380,727
+67,479
| +22% | +$1.22M | 2.45% | 6 |
|
|
2023
Q1 | $8.33M | Buy |
313,248
+8,675
| +3% | +$231K | 3.2% | 4 |
|
|
2022
Q4 | $5.89M | Buy |
304,573
+81,816
| +37% | +$1.58M | 2.44% | 4 |
|
|
2022
Q3 | $4.65M | Buy |
222,757
+10,547
| +5% | +$220K | 1.96% | 9 |
|
|
2022
Q2 | $1.7M | Buy |
212,210
+26,100
| +14% | +$209K | 0.73% | 37 |
|
|
2022
Q1 | $1.76M | Buy |
186,110
+11,850
| +7% | +$112K | 0.62% | 47 |
|
|
2021
Q4 | $2.35M | Buy |
174,260
+7,813
| +5% | +$105K | 0.77% | 31 |
|
|
2021
Q3 | $2.81M | Buy |
166,447
+15,336
| +10% | +$259K | 0.97% | 29 |
|
|
2021
Q2 | $4.41M | Buy |
+151,111
| New | +$4.41M | 1.46% | 15 |
|